Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313033) titled '[68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL)' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Hospices Civils de Lyon
Condition:
Lobular Carcinoma
Breast Cancer
Intervention:
Other: [68]GA-FAPI-46 PET scan
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 30, 2026
Target Sample Size: 45
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/stu...